# DMBX1

## Overview
DMBX1, or diencephalon/mesencephalon homeobox 1, is a gene that encodes a transcription factor belonging to the bicoid subfamily of homeodomain-containing proteins. This transcription factor plays a pivotal role in the development of the central nervous system, particularly influencing the formation and differentiation of the diencephalon and mesencephalon regions during embryogenesis. The DMBX1 protein is primarily active in the nucleus, where it binds to DNA to regulate the transcription of genes involved in neurogenesis and morphogenesis. Its expression is tightly regulated both spatially and temporally, ensuring precise control over developmental processes. Beyond its developmental roles, DMBX1 has been implicated in oncogenesis, particularly in lung adenocarcinoma and colorectal cancer, where it functions as a transcriptional repressor influencing cell cycle progression and tumor proliferation (Luo2019DMBX1; Zhou2016Epigenomewide; Zhang2022DMBX1).

## Structure


## Function
The DMBX1 gene encodes a transcription factor that is part of the bicoid subfamily of homeodomain-containing proteins. It plays a crucial role in the development of the brain and sensory organs, particularly during embryogenesis. DMBX1 is involved in regulating the transcription of target genes, influencing patterns of anatomical development, or morphogenesis, in animals (Luo2019DMBX1; Zhou2016Epigenomewide). 

In healthy human cells, DMBX1 is active in the nucleus, where it binds to DNA to modulate transcriptional activity. This gene is essential for the development of the central nervous system, including the diencephalon and mesencephalon regions, and is involved in neurogenesis, influencing neuronal differentiation and brain patterning (Luo2019DMBX1; Zhou2016Epigenomewide). 

DMBX1's expression is spatially and temporally regulated, meaning it is expressed at specific times and locations during development. This precise regulation is critical for its role in brain and sensory organ development, as well as in the regulation of progenitor cell cycles and differentiation in midbrain and retinal neurogenesis (Luo2019DMBX1; Zhang2022DMBX1).

## Clinical Significance
DMBX1 has been implicated in various cancers, notably lung adenocarcinoma (LUAD) and colorectal cancer (CRC). In LUAD, DMBX1 is overexpressed compared to normal lung tissues and is associated with poorer overall survival and advanced clinical stages. It functions as an oncogene by promoting tumor proliferation and cell cycle progression through the repression of OTX2-mediated transcription of p21, a cyclin-dependent kinase inhibitor. Knockdown of DMBX1 in LUAD cell lines results in reduced cell proliferation and induces G1/S cell cycle arrest, highlighting its potential as a therapeutic target and biomarker for diagnosis and prognosis in LUAD (Luo2019DMBX1).

In CRC, DMBX1 is also overexpressed and contributes to cancer progression by promoting cell proliferation and migration while inhibiting apoptosis. The oncogenic role of DMBX1 in CRC is linked to the regulation of c-Myc expression, a well-known oncogene. Knockdown of DMBX1 in CRC cells leads to decreased cell viability, reduced colony formation, increased apoptosis, and inhibited cell migration, suggesting its potential as a therapeutic target in CRC and possibly other digestive system carcinomas (Zhang2022DMBX1). These findings underscore the significance of DMBX1 in cancer biology and its potential as a target for cancer therapy.

## Interactions
DMBX1, a transcription factor, is involved in several interactions with other proteins, particularly in the context of lung adenocarcinoma (LUAD). One significant interaction is with the OTX2 protein. DMBX1 does not directly bind to the promoter region of the p21 gene, a cyclin-dependent kinase inhibitor crucial for cell cycle regulation. Instead, it interacts with OTX2, which does bind to the p21 promoter. This interaction is critical because OTX2 is known to activate cell cycle genes, and its silencing blocks the G1-S cell cycle transition. DMBX1 binds to OTX2, suppressing its ability to transcribe p21, as confirmed through co-immunoprecipitation experiments. The binding of OTX2 to the p21 promoter is reduced by the ectopic expression of DMBX1, indicating that DMBX1 represses OTX2-mediated transcription of p21 (Luo2019DMBX1).

In vivo experiments using xenograft tumor models demonstrated that silencing DMBX1 inhibited tumor growth, and this effect could be restored by knocking down either OTX2 or p21. Conversely, overexpression of DMBX1 promoted tumor proliferation, which was reversed by ectopic expression of OTX2 or p21. These findings suggest that DMBX1 promotes tumor growth via the OTX2-p21 axis, highlighting its role as a transcriptional repressor that interacts with OTX2 to regulate p21 expression (Luo2019DMBX1).


## References


[1. (Luo2019DMBX1) Jing Luo, Kaichao Liu, Yu Yao, Qi Sun, Xiufen Zheng, Biqing Zhu, Quanli Zhang, Lin Xu, Yi Shen, and Binhui Ren. Dmbx1 promotes tumor proliferation and regulates cell cycle progression via repressing otx2-mediated transcription of p21 in lung adenocarcinoma cell. Cancer Letters, 453:45â€“56, July 2019. URL: http://dx.doi.org/10.1016/j.canlet.2019.03.045, doi:10.1016/j.canlet.2019.03.045. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2019.03.045)

[2. (Zhou2016Epigenomewide) Fusheng Zhou, Changbing Shen, Jingkai Xu, Jing Gao, Xiaodong Zheng, Randy Ko, Jinfa Dou, Yuyan Cheng, Caihong Zhu, Shuangjun Xu, Xianfa Tang, Xianbo Zuo, Xianyong Yin, Yong Cui, Liangdan Sun, Lam C. Tsoi, Yi-Hsiang Hsu, Sen Yang, and Xuejun Zhang. Epigenome-wide association data implicates dna methylation-mediated genetic risk in psoriasis. Clinical Epigenetics, December 2016. URL: http://dx.doi.org/10.1186/s13148-016-0297-z, doi:10.1186/s13148-016-0297-z. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13148-016-0297-z)

3. (Zhang2022DMBX1) DMBX1 knockdown inhibits colorectal cancer cell proliferation and migration via down-regulating c-Myc expression. This article has 0 citations.